Samsung's biotech unit debuts in Seoul. Here's what to know.

SEOUL, South Korea (AP) — Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years.